Physician profile
Edward Miles
NPI 1336311349
$1,903.65
in general payments reported to CMS, 2019-2025
17 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,382 · 2021: $102 · 2023: $98.36 · 2024: $156 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $1,382.21 | 2019 | |
| Puma Biotechnology, INC. | $73.36 | 2023 | |
| Isoray, INC | $58.85 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $43.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.44 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $30.35 | 2024 | |
| Genentech USA, INC. | $29.46 | 2024 | Phesgo |
| Lilly USA, LLC | $29.10 | 2024 | Verzenio |
| Syndax Pharmaceuticals, INC. | $28.91 | 2025 | |
| Daiichi Sankyo INC. | $25.23 | 2025 | Enhertu |
| Merck Sharp & Dohme LLC | $25.13 | 2025 | Keytruda |
| Reflexion Medical, INC. | $25.00 | 2023 | Reflexion Medical Radiotherapy System |
| Servier Pharmaceuticals LLC | $24.67 | 2025 | |
| Eisai INC. | $24.08 | 2024 | |
| Incyte Corporation | $23.46 | 2024 | Jakafi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.90 | 2025 | Blenrep |
| Janssen Biotech, INC. | $17.17 | 2025 | Rybrevant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.